Category: Diseases & Conditions
Global Diseases & Conditions
-
Spectator Sports
... CAGR of 5.8% over the analysis period 2024-2030. Sports Team and Clubs, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$284.6 Billion by the end of ... Read More
-
Transdermal Scopolamine
... CAGR of 5.3% over the analysis period 2024-2030. The U.S. Market is Estimated at US$141.9 Million While China is Forecast to Grow at 5.1% CAGR The Transdermal Scopolamine market in the U.S. is estimated at ... Read More
-
Spring and Wire Products
... 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Springs, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$47.0 Billion by the end ... Read More
-
Automotive Wiper Component Aftermarket
... 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Wiper Blade Component, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$6.5 Billion by ... Read More
-
Flea and Tick Products
... 2030, growing at a CAGR of 7.9% over the analysis period 2024-2030. Chewable Products, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$7.3 Billion by the ... Read More
-
Hospitals and Outpatient Care Centers
... Trillion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.1 Trillion While China is Forecast to Grow at 7.6% CAGR The Hospitals and Outpatient ... Read More
-
Sports Management Software
... at a CAGR of 13.2% over the analysis period 2024-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$8.2 Billion by the end of ... Read More
-
Venturi Masks
... CAGR of 11.5% over the analysis period 2024-2030. COPD Application, one of the segments analyzed in the report, is expected to record a 13.5% CAGR and reach US$2.9 Billion by the end of the analysis ... Read More
-
Insulin Pens
... CAGR of 7.2% over the analysis period 2024-2030. Disposable Insulin Pens, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$11.6 Billion by the end of the ... Read More
-
Particle Therapy
... CAGR of 8.8% over the analysis period 2024-2030. Proton Therapy, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$2.3 Billion by the end of the analysis ... Read More
-
Pesticide Inert Ingredients
... at a CAGR of 6.2% over the analysis period 2024-2030. Emulsifiers, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$3.3 Billion by the end of the ... Read More
-
Therapeutic Respiratory Devices
... at a CAGR of 3.3% over the analysis period 2024-2030. Positive Airway Pressure Devices, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$32.3 Billion by the ... Read More
-
Fibromyalgia Therapeutics
... CAGR of 2.9% over the analysis period 2024-2030. Antiepileptics, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$2.1 Billion by the end of the analysis period. ... Read More
-
Heart Healthy Ingredients
... at a CAGR of 4.2% over the analysis period 2024-2030. Omega-3 Ingredient, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$12.4 Billion by the end of ... Read More
-
Wearable Fitness Technology
... at a CAGR of 13.3% over the analysis period 2024-2030. Smartwatches, one of the segments analyzed in the report, is expected to record a 15.0% CAGR and reach US$11.0 Billion by the end of the ... Read More
-
Sleep Apnea Diagnostic and Therapeutic Devices
... reach US$14.0 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Diagnostic Devices, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach ... Read More
-
Anti-Hypertensive Drugs
... CAGR of 2.7% over the analysis period 2024-2030. Calcium Channel Blockers, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$7.2 Billion by the end of the ... Read More
-
Walnut
... 2.9% over the analysis period 2024-2030. Black Walnuts, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$570.1 Million by the end of the analysis period. Growth ... Read More
-
Automotive Rubber-Molded Components
... at a CAGR of 5.4% over the analysis period 2024-2030. Ethylene Propylene Diene Monomer (EPDM) Material, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$31.1 Billion ... Read More
-
Neuromodulation
... 9.2% over the analysis period 2024-2030. Spinal Cord Stimulation, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$5.4 Billion by the end of the analysis period. ... Read More
-
Heavy-Duty Pumps
... CAGR of 4.8% over the analysis period 2024-2030. Centrifugal Pumps, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$19.1 Billion by the end of the analysis ... Read More
-
Hepatitis B Vaccines
... at a CAGR of 4.4% over the analysis period 2024-2030. Combination Vaccines, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.6 Billion by the end of ... Read More
-
High Pressure Pumps
... at a CAGR of 3.5% over the analysis period 2024-2030. Dynamic Pumps, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$2.0 Billion by the end of ... Read More
-
Missiles
... 4.7% over the analysis period 2024-2030. Surface-to-Surface Missiles, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$63.6 Billion by the end of the analysis period. Growth ... Read More
-
Automotive Lighting
... CAGR of 6.0% over the analysis period 2024-2030. Halogen Lighting, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$28.2 Billion by the end of the analysis ... Read More
Research Assistance
